Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Class A common stock, par value $0.0001 per share
-
Shares outstanding
-
1,261,707
-
Total 13F shares
-
8,482,878
-
Share change
-
+257,687
-
Total reported value
-
$92,728,769
-
Price per share
-
$10.95
-
Number of holders
-
32
-
Value change
-
+$3,070,186
-
Number of buys
-
12
-
Number of sells
-
14
Institutional Holders of Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) as of Q3 2023
As of 30 Sep 2023,
Semnur Pharmaceuticals, Inc. - Class A common stock, par value $0.0001 per share (DNQAF) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,482,878 shares.
The largest 10 holders included
First Trust Capital Management L.P., MIZUHO SECURITIES USA LLC, Periscope Capital Inc., Hudson Bay Capital Management LP, WOLVERINE ASSET MANAGEMENT LLC, ATW SPAC MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, BERKLEY W R CORP, Saba Capital Management, L.P., and Calamos Advisors LLC.
This page lists
32
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.